CD274 and non-small cell lung carcinoma: This non-linear correlation reappeared in an anti-PD-L1 study in NSCLC, in which atezolizumab compared with docetaxel was associated with improved ORR in the ≥50% PD-L1+ group but decreased ORR in the 1–49% group (217).